VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | Adapting the PERCEPT myeloma prehabilitation trial to virtual delivery during the COVID-19 pandemic

Orla McCourt, MSc, MCSP, University College London NHS Foundation Trust, London, UK, discusses the impact of the COVID-19 pandemic on the delivery of the PERCEPT myeloma prehabilitation trial, outlining the changes that were implemented to deliver the trial remotely, including substituting assessment measures and incorporating new measures to ensure participant safety. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter